LTP — Ltr Pharma Cashflow Statement
0.000.00%
- AU$70.58m
- AU$36.51m
- AU$0.05m
Annual cashflow statement for Ltr Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Changes in Working Capital | 0 | 0 | 0 | -0 |
Other Operating Cash Flow | ||||
Cash from Operating Activities | -0.029 | -0.568 | -1.54 | -5.09 |
Capital Expenditures | — | — | -0.002 | -0.002 |
Purchase of Fixed Assets | ||||
Cash from Investing Activities | — | — | -0.002 | -0.002 |
Financing Cash Flow Items | — | — | -0.069 | -0.504 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 0.178 | 2.34 | 1.38 | 6.5 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0.146 | 1.76 | -0.183 | 1.37 |